The evolving role of [18F]DCFPyL (Pylarify) PET/CT in the management of Prostate Cancer

被引：0
|
作者：
Jasaraj, Ranjit [1 ]
Khanal, Kishor [2 ]
Bhusal, Subarna [3 ]
Shrestha, Bimash [4 ]
Singh, Shashi [5 ]
机构：
[1] Mt Sinai Hosp Chicago, Chicago, IL USA
[2] Mem HealthCare Syst, Hollywood, FL USA
[3] KIST Med Coll, Lalitpur, Nepal
[4] Hosp Univ Penn, Philadelphia, PA 19104 USA
[5] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1443
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Repeatability of Quantitative [18F] Fluoromethylcholine PET/CT Measurements in Prostate Cancer
    Oprea-Lager, D. E.
    Kramer, G. M.
    van de Ven, P. M.
    van den Eertwegh, A. J. M.
    van Moorselaar, R. J. A.
    Hoekstra, O. S.
    Lammertsma, A. A.
    Boellaard, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S391 - S391
  • [42] [18F]NaF PET/CT Imaging Biomarkers in Metastatic Prostate Cancer
    Harmon, S.
    Perk, T.
    Lin, C.
    Eickhoff, J.
    Choyke, P.
    Dahut, W.
    Apolo, A.
    Humm, J.
    Larson, S.
    Morris, M. J.
    Perlman, S.
    Liu, G.
    Jeraj, R.
    [J]. MEDICAL PHYSICS, 2016, 43 (06) : 3691 - 3691
  • [43] Evaluation of 18F-DCFPyL PSMA PET/CT for Prostate Cancer: A Meta-Analysis
    Pan, Ke-Hao
    Wang, Jin-Feng
    Wang, Chun-Ying
    Nikzad, Abdul Aziz
    Kong, Fang Q.
    Jian, Li
    Zhang, Yin-Qiu
    Lu, Xiao-Ming
    Xu, Bin
    Wang, Ya-Li
    Chen, Ming
    [J]. FRONTIERS IN ONCOLOGY, 2021, 10
  • [44] Correlation of18F-DCFPyL PET/CT with multiparametric MRI and histopathology in localized prostate cancer
    Turkbey, Ismail
    Mena, Esther
    Harmon, Stephanie
    Czarniecki, Marcin
    Adler, Stephen
    Wood, Bradford
    Mease, Ronnie
    Pinto, Peter
    Pomper, Martin
    Lindenberg, Maria Liza
    Choyke, Peter
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [45] [18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer
    Beheshti, Mohsen
    Vali, Reza
    Langsteger, Werner
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (08) : 1316 - 1317
  • [46] [18F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients
    Nappi, Anna Giulia
    Ferrari, Cristina
    Mammucci, Paolo
    Rubini, Dino
    Lavelli, Valentina
    Sardaro, Angela
    Pisani, Antonio Rosario
    Rubini, Giuseppe
    [J]. CANCERS, 2022, 14 (06)
  • [47] Comparison of Diagnostic Sensitivity Between [18F]Florastamin and [18F]FDG PET/CT in the Patients with Prostate Cancer
    Lee, Inki
    Lim, Ilhan
    Byun, Byung Hyun
    Kim, Byung Il
    Choi, Chang Woon
    Lee, Kyo Chul
    Kang, Joo Hyun
    Chi, Dae Yoon
    Park, Jongwook
    Song, Kanghyon
    Lim, Sang Moo
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [48] Imaging characteristics of [18F]GE-148 ([18F]FACBC) PET/CT in subjects with prostate cancer
    Sorensen, Jens
    Johansson, Silvia
    Owenius, Rikard
    Lax, Michelle
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [49] PSA-Stratified Performance of [18F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer Patients under Androgen Deprivation Therapy
    Harsini, Sara
    Wilson, Don
    Benard, Francois
    [J]. DIAGNOSTICS, 2022, 12 (09)
  • [50] [18F]DCFPyL PET/CT in detection and localization of recurrent prostate cancer following prostatectomy including low PSA < 0.5 ng/mL
    Elisa Perry
    Arpit Talwar
    Kim Taubman
    Michael Ng
    Lih-Ming Wong
    Russell Booth
    Tom R. Sutherland
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2038 - 2046
12345